CNS Trial Readiness Checklist

Most CNS study teams don’t discover platform gaps at the start of their study. They discover them six months in — when query rates are climbing, a protocol amendment is stuck in a vendor queue, or a site coordinator is manually tracking LAR consent status in a spreadsheet. This checklist is a practical diagnostic for both scenarios: use it before your study launches to evaluate whether your platform is built for CNS complexity, or use it mid-study to identify where the cracks are before they become a crisis.

What’s Inside:

  • Enrollment Infrastructure: Is your recruitment and EDC working together, or are you re-entering data across systems?
  • LAR Consent Workflows: Does your platform handle legally authorized representative consent natively, or as a workaround?
  • eCOA Configuration: Are your cognitive assessments integrated with your study data, or reconciled manually?
  • Data Integrity & EDC Performance: Are your query rates, audit trails, and site adoption where they need to be?
  • Platform Resilience & Vendor Readiness: If something changes mid-study, do you have a plan?

Perfect for:

  • VPs and Directors of Clinical Operations running Phase II–III CNS studies
  • Clinical Data Managers assessing platform performance or preparing for a transition
  • Research Leadership at Academic Medical Centers sponsoring investigator-initiated CNS trials
  • Site Operations Teams managing coordinators across multi-site CNS programs

Download the checklist and work through it with your study team — any unchecked box is a conversation worth having before it becomes urgent.

Marketing / Communications Opt-in

Gated CNS Sales Play Form

Marketing / Communications Opt-in

Marketing / Communications Opt-in

Which Solutions
would you like a quote for?